<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
<head>
<!-- 2021-09-27 Mon 11:54 -->
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>flo - hallmarks of cancer (2011) reading</title>
<meta name="generator" content="Org mode" />
<meta name="author" content="Exr0n" />
<style type="text/css">
 <!--/*--><![CDATA[/*><!--*/
  .title  { text-align: center;
             margin-bottom: .2em; }
  .subtitle { text-align: center;
              font-size: medium;
              font-weight: bold;
              margin-top:0; }
  .todo   { font-family: monospace; color: red; }
  .done   { font-family: monospace; color: green; }
  .priority { font-family: monospace; color: orange; }
  .tag    { background-color: #eee; font-family: monospace;
            padding: 2px; font-size: 80%; font-weight: normal; }
  .timestamp { color: #bebebe; }
  .timestamp-kwd { color: #5f9ea0; }
  .org-right  { margin-left: auto; margin-right: 0px;  text-align: right; }
  .org-left   { margin-left: 0px;  margin-right: auto; text-align: left; }
  .org-center { margin-left: auto; margin-right: auto; text-align: center; }
  .underline { text-decoration: underline; }
  #postamble p, #preamble p { font-size: 90%; margin: .2em; }
  p.verse { margin-left: 3%; }
  pre {
    border: 1px solid #ccc;
    box-shadow: 3px 3px 3px #eee;
    padding: 8pt;
    font-family: monospace;
    overflow: auto;
    margin: 1.2em;
  }
  pre.src {
    position: relative;
    overflow: auto;
    padding-top: 1.2em;
  }
  pre.src:before {
    display: none;
    position: absolute;
    background-color: white;
    top: -10px;
    right: 10px;
    padding: 3px;
    border: 1px solid black;
  }
  pre.src:hover:before { display: inline; margin-top: 14px;}
  /* Languages per Org manual */
  pre.src-asymptote:before { content: 'Asymptote'; }
  pre.src-awk:before { content: 'Awk'; }
  pre.src-C:before { content: 'C'; }
  /* pre.src-C++ doesn't work in CSS */
  pre.src-clojure:before { content: 'Clojure'; }
  pre.src-css:before { content: 'CSS'; }
  pre.src-D:before { content: 'D'; }
  pre.src-ditaa:before { content: 'ditaa'; }
  pre.src-dot:before { content: 'Graphviz'; }
  pre.src-calc:before { content: 'Emacs Calc'; }
  pre.src-emacs-lisp:before { content: 'Emacs Lisp'; }
  pre.src-fortran:before { content: 'Fortran'; }
  pre.src-gnuplot:before { content: 'gnuplot'; }
  pre.src-haskell:before { content: 'Haskell'; }
  pre.src-hledger:before { content: 'hledger'; }
  pre.src-java:before { content: 'Java'; }
  pre.src-js:before { content: 'Javascript'; }
  pre.src-latex:before { content: 'LaTeX'; }
  pre.src-ledger:before { content: 'Ledger'; }
  pre.src-lisp:before { content: 'Lisp'; }
  pre.src-lilypond:before { content: 'Lilypond'; }
  pre.src-lua:before { content: 'Lua'; }
  pre.src-matlab:before { content: 'MATLAB'; }
  pre.src-mscgen:before { content: 'Mscgen'; }
  pre.src-ocaml:before { content: 'Objective Caml'; }
  pre.src-octave:before { content: 'Octave'; }
  pre.src-org:before { content: 'Org mode'; }
  pre.src-oz:before { content: 'OZ'; }
  pre.src-plantuml:before { content: 'Plantuml'; }
  pre.src-processing:before { content: 'Processing.js'; }
  pre.src-python:before { content: 'Python'; }
  pre.src-R:before { content: 'R'; }
  pre.src-ruby:before { content: 'Ruby'; }
  pre.src-sass:before { content: 'Sass'; }
  pre.src-scheme:before { content: 'Scheme'; }
  pre.src-screen:before { content: 'Gnu Screen'; }
  pre.src-sed:before { content: 'Sed'; }
  pre.src-sh:before { content: 'shell'; }
  pre.src-sql:before { content: 'SQL'; }
  pre.src-sqlite:before { content: 'SQLite'; }
  /* additional languages in org.el's org-babel-load-languages alist */
  pre.src-forth:before { content: 'Forth'; }
  pre.src-io:before { content: 'IO'; }
  pre.src-J:before { content: 'J'; }
  pre.src-makefile:before { content: 'Makefile'; }
  pre.src-maxima:before { content: 'Maxima'; }
  pre.src-perl:before { content: 'Perl'; }
  pre.src-picolisp:before { content: 'Pico Lisp'; }
  pre.src-scala:before { content: 'Scala'; }
  pre.src-shell:before { content: 'Shell Script'; }
  pre.src-ebnf2ps:before { content: 'ebfn2ps'; }
  /* additional language identifiers per "defun org-babel-execute"
       in ob-*.el */
  pre.src-cpp:before  { content: 'C++'; }
  pre.src-abc:before  { content: 'ABC'; }
  pre.src-coq:before  { content: 'Coq'; }
  pre.src-groovy:before  { content: 'Groovy'; }
  /* additional language identifiers from org-babel-shell-names in
     ob-shell.el: ob-shell is the only babel language using a lambda to put
     the execution function name together. */
  pre.src-bash:before  { content: 'bash'; }
  pre.src-csh:before  { content: 'csh'; }
  pre.src-ash:before  { content: 'ash'; }
  pre.src-dash:before  { content: 'dash'; }
  pre.src-ksh:before  { content: 'ksh'; }
  pre.src-mksh:before  { content: 'mksh'; }
  pre.src-posh:before  { content: 'posh'; }
  /* Additional Emacs modes also supported by the LaTeX listings package */
  pre.src-ada:before { content: 'Ada'; }
  pre.src-asm:before { content: 'Assembler'; }
  pre.src-caml:before { content: 'Caml'; }
  pre.src-delphi:before { content: 'Delphi'; }
  pre.src-html:before { content: 'HTML'; }
  pre.src-idl:before { content: 'IDL'; }
  pre.src-mercury:before { content: 'Mercury'; }
  pre.src-metapost:before { content: 'MetaPost'; }
  pre.src-modula-2:before { content: 'Modula-2'; }
  pre.src-pascal:before { content: 'Pascal'; }
  pre.src-ps:before { content: 'PostScript'; }
  pre.src-prolog:before { content: 'Prolog'; }
  pre.src-simula:before { content: 'Simula'; }
  pre.src-tcl:before { content: 'tcl'; }
  pre.src-tex:before { content: 'TeX'; }
  pre.src-plain-tex:before { content: 'Plain TeX'; }
  pre.src-verilog:before { content: 'Verilog'; }
  pre.src-vhdl:before { content: 'VHDL'; }
  pre.src-xml:before { content: 'XML'; }
  pre.src-nxml:before { content: 'XML'; }
  /* add a generic configuration mode; LaTeX export needs an additional
     (add-to-list 'org-latex-listings-langs '(conf " ")) in .emacs */
  pre.src-conf:before { content: 'Configuration File'; }

  table { border-collapse:collapse; }
  caption.t-above { caption-side: top; }
  caption.t-bottom { caption-side: bottom; }
  td, th { vertical-align:top;  }
  th.org-right  { text-align: center;  }
  th.org-left   { text-align: center;   }
  th.org-center { text-align: center; }
  td.org-right  { text-align: right;  }
  td.org-left   { text-align: left;   }
  td.org-center { text-align: center; }
  dt { font-weight: bold; }
  .footpara { display: inline; }
  .footdef  { margin-bottom: 1em; }
  .figure { padding: 1em; }
  .figure p { text-align: center; }
  .equation-container {
    display: table;
    text-align: center;
    width: 100%;
  }
  .equation {
    vertical-align: middle;
  }
  .equation-label {
    display: table-cell;
    text-align: right;
    vertical-align: middle;
  }
  .inlinetask {
    padding: 10px;
    border: 2px solid gray;
    margin: 10px;
    background: #ffffcc;
  }
  #org-div-home-and-up
   { text-align: right; font-size: 70%; white-space: nowrap; }
  textarea { overflow-x: auto; }
  .linenr { font-size: smaller }
  .code-highlighted { background-color: #ffff00; }
  .org-info-js_info-navigation { border-style: none; }
  #org-info-js_console-label
    { font-size: 10px; font-weight: bold; white-space: nowrap; }
  .org-info-js_search-highlight
    { background-color: #ffff00; color: #000000; font-weight: bold; }
  .org-svg { width: 90%; }
  /*]]>*/-->
</style>
<link rel="stylesheet" href="/global.css" type="text/css"/>
<script type="text/javascript">
// @license magnet:?xt=urn:btih:e95b018ef3580986a04669f1b5879592219e2a7a&dn=public-domain.txt Public Domain
<!--/*--><![CDATA[/*><!--*/
     function CodeHighlightOn(elem, id)
     {
       var target = document.getElementById(id);
       if(null != target) {
         elem.classList.add("code-highlighted");
         target.classList.add("code-highlighted");
       }
     }
     function CodeHighlightOff(elem, id)
     {
       var target = document.getElementById(id);
       if(null != target) {
         elem.classList.remove("code-highlighted");
         target.classList.remove("code-highlighted");
       }
     }
    /*]]>*///-->
// @license-end
</script>
</head>
<body>
<div id="preamble" class="status">
<div class="header"><span class="site"><a href="https://taproot3.sanity.gq">TR3.5</a></span></div><div class="datarow"><h1 class="title">flo - hallmarks of cancer (2011) reading</h1> <h2 class="subtitle"></h2> <span class="author">Exr0n</span> <span class="date">2021-09-27 Mon 11:51</date></div>
</div>
<div id="content">
<div id="table-of-backlinks"><h2>Backlinks</h2><ul></ul></div><div id="table-of-contents">
<h2>Table of Contents</h2>
<div id="text-table-of-contents">
<ul>
<li><a href="#orge3e0f35">1. sources&#xa0;&#xa0;&#xa0;<span class="tag"><span class="source">source</span></span></a>
<ul>
<li><a href="#org228e4e0">1.1. assignment: https://nuevaschool.instructure.com/courses/3087/assignments/56036</a></li>
<li><a href="#org0db53dd">1.2. reading: Hallmarks of Cancer PDF</a></li>
</ul>
</li>
<li><a href="#org546473e">2. Flow</a>
<ul>
<li><a href="#org61541dc">2.1. Abstract</a>
<ul>
<li><a href="#org8925a16">2.1.1. hallmarks include</a></li>
<li><a href="#org1d3b074">2.1.2. theese hallmarks are newer</a></li>
<li><a href="#orgb7abc94">2.1.3. underlying</a></li>
</ul>
</li>
<li><a href="#org72c8e5f">2.2. Introduction</a>
<ul>
<li><a href="#org6d08319">2.2.1. Cancer cells evolve into cancer cells because they need to be cancer cells??</a></li>
<li><a href="#org851b76b">2.2.2. tumors are not simple / idle 'insular masses of proliferating cancer cells'</a></li>
<li><a href="#org3eebad9">2.2.3. "recruited" normal cells (or 'stromal cells') are active parts of the tumor</a></li>
<li><a href="#org480c49b">2.2.4. 'the biology of tumors can no longer be understood simply by enumerating the traits of the cancer cells but instead must encompass the contributions of the "tumor microenvironment" to tumorigenesis.'</a></li>
<li><a href="#org905a52b">2.2.5. purpose is to consider new hallmarks that have been found or note that old ones weren't as general as we thought</a></li>
</ul>
</li>
<li><a href="#org3f1873f">2.3. section: 'An Emerging Hallmark: Evading Immune Destruction'</a>
<ul>
<li><a href="#org7ad6267">2.3.1. the immune system usually eradicates the 'formation and progression of incipient neoplasias, late-stage tumors, and micrometastases', so why not in these cancers?</a></li>
<li><a href="#orgbe3314a">2.3.2. 'long standing theory of immune surveillance' -&gt; something went interesting</a></li>
<li><a href="#orgaba6ad3">2.3.3. more cancer in immunocompromised individuals</a></li>
<li><a href="#org536ef61">2.3.4. 'genetically engineered mice and clinical epidemeology suggest that the immune system' actually hurts cancer</a></li>
<li><a href="#org42177ae">2.3.5. transplantation experiments</a></li>
<li><a href="#orgc36cb01">2.3.6. the immune system probably includes antitumoral responses</a></li>
<li><a href="#orgcc875ca">2.3.7. <span class="todo TODO">TODO</span> 'still, the epidemiology of chronically immunosupressed patients does not indicate significantly increased incidences of the major forms of nonviral human cancer'</a></li>
<li><a href="#org92d1592">2.3.8. <span class="todo TODO">TODO</span> something about HIV patients who lack T and B cells and how they should still be able to fight cancer with NK cells and CTLs</a></li>
<li><a href="#org1949386">2.3.9. that was oversimplified as the tumor might also be actively supressing immune responses</a></li>
<li><a href="#org83ac20e">2.3.10. it is so far unclear whether the immune system plays a large enough role to be considered a hallmark of cancer</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#orgb3db11a">3. Vocab</a>
<ul>
<li><a href="#org63cae4d">3.1. neoplastic disease</a>
<ul>
<li><a href="#org695e884">3.1.1. anything that causes tumor growth (malignant or benign)</a></li>
</ul>
</li>
<li><a href="#orgf163691">3.2. ostensibly</a>
<ul>
<li><a href="#org6169234">3.2.1. maybe 'technically'?'</a></li>
</ul>
</li>
<li><a href="#orgf8d713c">3.3. tumor microenvironment</a>
<ul>
<li><a href="#org3b66623">3.3.1. presumably inflammation, recruited normal cells, and other stuff that helps the tumor grow</a></li>
</ul>
</li>
<li><a href="#org1505653">3.4. pathogenisis</a>
<ul>
<li><a href="#orgc60ab01">3.4.1. evolution of 'pathogen' (cancer)</a></li>
</ul>
</li>
<li><a href="#org1ac3897">3.5. ancillary proposition</a>
<ul>
<li><a href="#org1888166">3.5.1. maybe the starting / base proposition</a></li>
</ul>
</li>
<li><a href="#org436249b">3.6. insular masses</a>
<ul>
<li><a href="#org3ee66e8">3.6.1. stagnant or something, simple</a></li>
</ul>
</li>
<li><a href="#org8058b50">3.7. heterotypic interactions</a>
<ul>
<li><a href="#orga0c8e13">3.7.1. many types of interactions</a></li>
</ul>
</li>
<li><a href="#org75eb642">3.8. tumorigenisis</a>
<ul>
<li><a href="#orgbd3d233">3.8.1. the growth / development of a tumor?</a></li>
</ul>
</li>
<li><a href="#orge61a0b0">3.9. neoplasias</a>
<ul>
<li><a href="#org6ffda23">3.9.1. new uncontrolled growth of cells</a></li>
</ul>
</li>
<li><a href="#org6c192d1">3.10. micrometastases</a>
<ul>
<li><a href="#org8889ec3">3.10.1. clumps of cancer cells that spread around the body</a></li>
</ul>
</li>
<li><a href="#org2ba3a80">3.11. etiology</a>
<ul>
<li><a href="#org5efb006">3.11.1. study of cancer?</a></li>
</ul>
</li>
<li><a href="#orgd0b13f6">3.12. immunogenic</a>
<ul>
<li><a href="#orgb94e1df">3.12.1. easily detected by the immune system</a></li>
</ul>
</li>
<li><a href="#orgd5838f3">3.13. immunoediting</a>
<ul>
<li><a href="#orgd0b824b">3.13.1. "natural selection" by the immune system</a></li>
</ul>
</li>
<li><a href="#org87851ff">3.14. prognosis</a>
<ul>
<li><a href="#org23c4df3">3.14.1. a prediction of the outcome of a cancer (or disease in general, apparently)</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</div>
<div id="outline-container-orge3e0f35" class="outline-2">
<h2 id="orge3e0f35"><span class="section-number-2">1</span> sources&#xa0;&#xa0;&#xa0;<span class="tag"><span class="source">source</span></span></h2>
<div class="outline-text-2" id="text-1">
</div>
<div id="outline-container-org228e4e0" class="outline-3">
<h3 id="org228e4e0"><span class="section-number-3">1.1</span> assignment: <a href="https://nuevaschool.instructure.com/courses/3087/assignments/56036">https://nuevaschool.instructure.com/courses/3087/assignments/56036</a></h3>
</div>
<div id="outline-container-org0db53dd" class="outline-3">
<h3 id="org0db53dd"><span class="section-number-3">1.2</span> reading: <a href="KBsrcHallmarksOfCancer2011Reading.pdf">Hallmarks of Cancer PDF</a></h3>
</div>
</div>
<div id="outline-container-org546473e" class="outline-2">
<h2 id="org546473e"><span class="section-number-2">2</span> Flow</h2>
<div class="outline-text-2" id="text-2">
</div>
<div id="outline-container-org61541dc" class="outline-3">
<h3 id="org61541dc"><span class="section-number-3">2.1</span> Abstract</h3>
<div class="outline-text-3" id="text-2-1">
</div>
<div id="outline-container-org8925a16" class="outline-4">
<h4 id="org8925a16"><span class="section-number-4">2.1.1</span> hallmarks include</h4>
<div class="outline-text-4" id="text-2-1-1">
</div>
<ol class="org-ol">
<li><a id="orgefb5544"></a>sustaining proliferative signaling<br /></li>
<li><a id="org30e87fe"></a>evading growth suppressors<br /></li>
<li><a id="orge2f218c"></a>resisting cell death<br /></li>
<li><a id="orge312588"></a>enabling replicative immortality<br /></li>
<li><a id="org769f2e3"></a>inducing ingiogenesis<br /></li>
<li><a id="org6bd917d"></a>activating invasion and metastasis<br /></li>
</ol>
</div>
<div id="outline-container-org1d3b074" class="outline-4">
<h4 id="org1d3b074"><span class="section-number-4">2.1.2</span> theese hallmarks are newer</h4>
<div class="outline-text-4" id="text-2-1-2">
</div>
<ol class="org-ol">
<li><a id="org47a6060"></a>reprogramming of energy metabolism<br /></li>
<li><a id="org45526f5"></a>evading immune destruction<br /></li>
</ol>
</div>
<div id="outline-container-orgb7abc94" class="outline-4">
<h4 id="orgb7abc94"><span class="section-number-4">2.1.3</span> underlying</h4>
<div class="outline-text-4" id="text-2-1-3">
</div>
<ol class="org-ol">
<li><a id="orgef1c70d"></a>genome instability<br />
<ol class="org-ol">
<li><a id="org13fcb81"></a>genetic diversity that expedites acquisition of hallmarks<br /></li>
</ol>
</li>
<li><a id="orge688e31"></a>inflammation<br />
<ol class="org-ol">
<li><a id="org76b2a85"></a>"fosters multiple hallmark functions"<br /></li>
</ol>
</li>
</ol>
</div>
</div>
<div id="outline-container-org72c8e5f" class="outline-3">
<h3 id="org72c8e5f"><span class="section-number-3">2.2</span> Introduction</h3>
<div class="outline-text-3" id="text-2-2">
</div>
<div id="outline-container-org6d08319" class="outline-4">
<h4 id="org6d08319"><span class="section-number-4">2.2.1</span> Cancer cells evolve into cancer cells because they need to be cancer cells??</h4>
<div class="outline-text-4" id="text-2-2-1">
</div>
<ol class="org-ol">
<li><a id="org63c7708"></a><span class="todo TODO">TODO</span> why do tumors have "the need &#x2026; to acquire the traints that enable them to become tumorigenic and ultimately malignant"?&#xa0;&#xa0;&#xa0;<span class="tag"><span class="question">question</span></span><br /></li>
</ol>
</div>
<div id="outline-container-org851b76b" class="outline-4">
<h4 id="org851b76b"><span class="section-number-4">2.2.2</span> tumors are not simple / idle 'insular masses of proliferating cancer cells'</h4>
</div>
<div id="outline-container-org3eebad9" class="outline-4">
<h4 id="org3eebad9"><span class="section-number-4">2.2.3</span> "recruited" normal cells (or 'stromal cells') are active parts of the tumor</h4>
</div>
<div id="outline-container-org480c49b" class="outline-4">
<h4 id="org480c49b"><span class="section-number-4">2.2.4</span> 'the biology of tumors can no longer be understood simply by enumerating the traits of the cancer cells but instead must encompass the contributions of the "tumor microenvironment" to tumorigenesis.'</h4>
</div>
<div id="outline-container-org905a52b" class="outline-4">
<h4 id="org905a52b"><span class="section-number-4">2.2.5</span> purpose is to consider new hallmarks that have been found or note that old ones weren't as general as we thought</h4>
</div>
</div>
<div id="outline-container-org3f1873f" class="outline-3">
<h3 id="org3f1873f"><span class="section-number-3">2.3</span> section: 'An Emerging Hallmark: Evading Immune Destruction'</h3>
<div class="outline-text-3" id="text-2-3">
</div>
<div id="outline-container-org7ad6267" class="outline-4">
<h4 id="org7ad6267"><span class="section-number-4">2.3.1</span> the immune system usually eradicates the 'formation and progression of incipient neoplasias, late-stage tumors, and micrometastases', so why not in these cancers?</h4>
</div>
<div id="outline-container-orgbe3314a" class="outline-4">
<h4 id="orgbe3314a"><span class="section-number-4">2.3.2</span> 'long standing theory of immune surveillance' -&gt; something went interesting</h4>
<div class="outline-text-4" id="text-2-3-2">
</div>
<ol class="org-ol">
<li><a id="org9038c72"></a>'cells and tissues are constantly monitored'<br /></li>
<li><a id="orgf35d734"></a>surveillance should elim cancer cells before they grow into tumors<br /></li>
<li><a id="orgf497a5e"></a>thus, grown tumors have either hid from surveillance or limited the 'extent of immunological killing'<br /></li>
</ol>
</div>
<div id="outline-container-orgaba6ad3" class="outline-4">
<h4 id="orgaba6ad3"><span class="section-number-4">2.3.3</span> more cancer in immunocompromised individuals</h4>
<div class="outline-text-4" id="text-2-3-3">
</div>
<ol class="org-ol">
<li><a id="org0fe4a8b"></a>but these are virus-induced cancers<br />
<ol class="org-ol">
<li><a id="orgacc443a"></a>so helping these people = reducing viral infilltration<br /></li>
</ol>
</li>
<li><a id="org07c781f"></a>other cancers still evade the immune system<br /></li>
</ol>
</div>
<div id="outline-container-org536ef61" class="outline-4">
<h4 id="org536ef61"><span class="section-number-4">2.3.4</span> 'genetically engineered mice and clinical epidemeology suggest that the immune system' actually hurts cancer</h4>
<div class="outline-text-4" id="text-2-3-4">
</div>
<ol class="org-ol">
<li><a id="org4a9fd01"></a>mice that are engineered to lack some immune parts got cancer faster/stronger/more<br />
<ol class="org-ol">
<li><a id="org1020a7a"></a>these guys are important in fighting cancer<br />
<ol class="org-ol">
<li><a id="org5dac689"></a>CD8^+ cytotoxic T lymphocytes (CTLs)<br /></li>
<li><a id="orged527bd"></a>CD4^+ T<sub>h1</sub> helper T cells<br /></li>
<li><a id="org40bc723"></a>natural killer (NK) cells<br /></li>
</ol>
</li>
<li><a id="orgfe6a672"></a>'demonstrable increase in tumor incidence'<br /></li>
<li><a id="orgbbf9a42"></a>lacking multiple -&gt; 'more susceptible to cancer development'<br /></li>
<li><a id="orgd2ab7b9"></a>'both the innate and adaptive cellular arms of the immune system are able to contribute significantly to immune surveillance and thus tumor eradication'&#xa0;&#xa0;&#xa0;<span class="tag"><span class="conclusion">conclusion</span></span><br /></li>
</ol>
</li>
</ol>
</div>
<div id="outline-container-org42177ae" class="outline-4">
<h4 id="org42177ae"><span class="section-number-4">2.3.5</span> transplantation experiments</h4>
<div class="outline-text-4" id="text-2-3-5">
</div>
<ol class="org-ol">
<li><a id="org872360d"></a>cancer cells from immunodeficient mice have a bad time in normal mice<br /></li>
<li><a id="org4c083ef"></a>cancer cells from normal mice can initiate tumors in both types of hosts<br /></li>
<li><a id="org2cdb280"></a>maybe some cancer cells are more easily detected and those would normally die in normal hosts but live in comprimised hosts, but when transplanted they meet a competent immune system and die&#xa0;&#xa0;&#xa0;<span class="tag"><span class="conclusion">conclusion</span></span><br /></li>
<li><a id="org4012a98"></a>Open question: do some carcinogens tend to induce more/less immunogenic cancer cells?&#xa0;&#xa0;&#xa0;<span class="tag"><span class="nextstep">nextstep</span></span><br /></li>
</ol>
</div>
<div id="outline-container-orgc36cb01" class="outline-4">
<h4 id="orgc36cb01"><span class="section-number-4">2.3.6</span> the immune system probably includes antitumoral responses</h4>
<div class="outline-text-4" id="text-2-3-6">
</div>
<ol class="org-ol">
<li><a id="orgf633793"></a>patients with colon and ovarian tumors who have lots of CTLs and NK cells have better prognosis<br />
<ol class="org-ol">
<li><a id="orgf69a346"></a>evidence is not as strong for other cancers&#xa0;&#xa0;&#xa0;<span class="tag"><span class="nextstep">nextstep</span></span><br /></li>
</ol>
</li>
<li><a id="org07a4d35"></a>immunosupressed organ recievers got cancer from the donor<br />
<ol class="org-ol">
<li><a id="orgf4f2117"></a>suggests doner had immune system which held cancer down until organ was transplanted<br /></li>
</ol>
</li>
</ol>
</div>
<div id="outline-container-orgcc875ca" class="outline-4">
<h4 id="orgcc875ca"><span class="section-number-4">2.3.7</span> <span class="todo TODO">TODO</span> 'still, the epidemiology of chronically immunosupressed patients does not indicate significantly increased incidences of the major forms of nonviral human cancer'</h4>
</div>
<div id="outline-container-org92d1592" class="outline-4">
<h4 id="org92d1592"><span class="section-number-4">2.3.8</span> <span class="todo TODO">TODO</span> something about HIV patients who lack T and B cells and how they should still be able to fight cancer with NK cells and CTLs</h4>
</div>
<div id="outline-container-org1949386" class="outline-4">
<h4 id="org1949386"><span class="section-number-4">2.3.9</span> that was oversimplified as the tumor might also be actively supressing immune responses</h4>
<div class="outline-text-4" id="text-2-3-9">
</div>
<ol class="org-ol">
<li><a id="org6570975"></a>may 'paralyze infiltrating CTLs and NK cells by secreting TGF-&beta; or other immunosuppressive factors'<br /></li>
<li><a id="orgad757d0"></a>'more subtle mechinisms .. recruitment of inflamatory cells that are actively immunosuppressive'<br />
<ol class="org-ol">
<li><a id="orgd445fb7"></a>'regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs)'<br /></li>
</ol>
</li>
</ol>
</div>
<div id="outline-container-org83ac20e" class="outline-4">
<h4 id="org83ac20e"><span class="section-number-4">2.3.10</span> it is so far unclear whether the immune system plays a large enough role to be considered a hallmark of cancer</h4>
</div>
</div>
</div>
<div id="outline-container-orgb3db11a" class="outline-2">
<h2 id="orgb3db11a"><span class="section-number-2">3</span> Vocab</h2>
<div class="outline-text-2" id="text-3">
</div>
<div id="outline-container-org63cae4d" class="outline-3">
<h3 id="org63cae4d"><span class="section-number-3">3.1</span> neoplastic disease</h3>
<div class="outline-text-3" id="text-3-1">
</div>
<div id="outline-container-org695e884" class="outline-4">
<h4 id="org695e884"><span class="section-number-4">3.1.1</span> anything that causes tumor growth (malignant or benign)</h4>
</div>
</div>
<div id="outline-container-orgf163691" class="outline-3">
<h3 id="orgf163691"><span class="section-number-3">3.2</span> ostensibly</h3>
<div class="outline-text-3" id="text-3-2">
</div>
<div id="outline-container-org6169234" class="outline-4">
<h4 id="org6169234"><span class="section-number-4">3.2.1</span> maybe 'technically'?'</h4>
</div>
</div>
<div id="outline-container-orgf8d713c" class="outline-3">
<h3 id="orgf8d713c"><span class="section-number-3">3.3</span> tumor microenvironment</h3>
<div class="outline-text-3" id="text-3-3">
</div>
<div id="outline-container-org3b66623" class="outline-4">
<h4 id="org3b66623"><span class="section-number-4">3.3.1</span> presumably inflammation, recruited normal cells, and other stuff that helps the tumor grow</h4>
</div>
</div>
<div id="outline-container-org1505653" class="outline-3">
<h3 id="org1505653"><span class="section-number-3">3.4</span> pathogenisis</h3>
<div class="outline-text-3" id="text-3-4">
</div>
<div id="outline-container-orgc60ab01" class="outline-4">
<h4 id="orgc60ab01"><span class="section-number-4">3.4.1</span> evolution of 'pathogen' (cancer)</h4>
</div>
</div>
<div id="outline-container-org1ac3897" class="outline-3">
<h3 id="org1ac3897"><span class="section-number-3">3.5</span> ancillary proposition</h3>
<div class="outline-text-3" id="text-3-5">
</div>
<div id="outline-container-org1888166" class="outline-4">
<h4 id="org1888166"><span class="section-number-4">3.5.1</span> maybe the starting / base proposition</h4>
</div>
</div>
<div id="outline-container-org436249b" class="outline-3">
<h3 id="org436249b"><span class="section-number-3">3.6</span> insular masses</h3>
<div class="outline-text-3" id="text-3-6">
</div>
<div id="outline-container-org3ee66e8" class="outline-4">
<h4 id="org3ee66e8"><span class="section-number-4">3.6.1</span> stagnant or something, simple</h4>
</div>
</div>
<div id="outline-container-org8058b50" class="outline-3">
<h3 id="org8058b50"><span class="section-number-3">3.7</span> heterotypic interactions</h3>
<div class="outline-text-3" id="text-3-7">
</div>
<div id="outline-container-orga0c8e13" class="outline-4">
<h4 id="orga0c8e13"><span class="section-number-4">3.7.1</span> many types of interactions</h4>
</div>
</div>
<div id="outline-container-org75eb642" class="outline-3">
<h3 id="org75eb642"><span class="section-number-3">3.8</span> tumorigenisis</h3>
<div class="outline-text-3" id="text-3-8">
</div>
<div id="outline-container-orgbd3d233" class="outline-4">
<h4 id="orgbd3d233"><span class="section-number-4">3.8.1</span> the growth / development of a tumor?</h4>
</div>
</div>
<div id="outline-container-orge61a0b0" class="outline-3">
<h3 id="orge61a0b0"><span class="section-number-3">3.9</span> neoplasias</h3>
<div class="outline-text-3" id="text-3-9">
</div>
<div id="outline-container-org6ffda23" class="outline-4">
<h4 id="org6ffda23"><span class="section-number-4">3.9.1</span> new uncontrolled growth of cells</h4>
</div>
</div>
<div id="outline-container-org6c192d1" class="outline-3">
<h3 id="org6c192d1"><span class="section-number-3">3.10</span> micrometastases</h3>
<div class="outline-text-3" id="text-3-10">
</div>
<div id="outline-container-org8889ec3" class="outline-4">
<h4 id="org8889ec3"><span class="section-number-4">3.10.1</span> clumps of cancer cells that spread around the body</h4>
</div>
</div>
<div id="outline-container-org2ba3a80" class="outline-3">
<h3 id="org2ba3a80"><span class="section-number-3">3.11</span> etiology</h3>
<div class="outline-text-3" id="text-3-11">
</div>
<div id="outline-container-org5efb006" class="outline-4">
<h4 id="org5efb006"><span class="section-number-4">3.11.1</span> study of cancer?</h4>
</div>
</div>
<div id="outline-container-orgd0b13f6" class="outline-3">
<h3 id="orgd0b13f6"><span class="section-number-3">3.12</span> immunogenic</h3>
<div class="outline-text-3" id="text-3-12">
</div>
<div id="outline-container-orgb94e1df" class="outline-4">
<h4 id="orgb94e1df"><span class="section-number-4">3.12.1</span> easily detected by the immune system</h4>
</div>
</div>
<div id="outline-container-orgd5838f3" class="outline-3">
<h3 id="orgd5838f3"><span class="section-number-3">3.13</span> immunoediting</h3>
<div class="outline-text-3" id="text-3-13">
</div>
<div id="outline-container-orgd0b824b" class="outline-4">
<h4 id="orgd0b824b"><span class="section-number-4">3.13.1</span> "natural selection" by the immune system</h4>
</div>
</div>
<div id="outline-container-org87851ff" class="outline-3">
<h3 id="org87851ff"><span class="section-number-3">3.14</span> prognosis</h3>
<div class="outline-text-3" id="text-3-14">
</div>
<div id="outline-container-org23c4df3" class="outline-4">
<h4 id="org23c4df3"><span class="section-number-4">3.14.1</span> a prediction of the outcome of a cancer (or disease in general, apparently)</h4>
<div class="outline-text-4" id="text-3-14-1">
</div>
</div>
</div>
</div>
</div>
</body>
</html>
